Vivo Capital
Venture capital firm · Founded 1996
Palo Alto-based healthcare investment firm founded in 1996, investing across venture capital, private equity and public equity in biotechnology and medical devices, with offices in Beijing, Shanghai, Hong Kong and Taipei; historically about 70% biotech and 30% devices, an early backer of Sinovac, and investing from a roughly $1.4B Fund IX.
Tier reflects published scale and track-record signals. It is not a rating of the firm as a partner.
This profile is unclaimed. Built from public sources. If you're a partner or employee at Vivo Capital, you can claim it.
Claim this profileHow claiming worksKey numbers
Assets under management
$5.3B
Latest fund
Vivo Opportunity Fund (third cycle)$740M · 2025
Funds
LAST CHECKED NOV 2026
Check size
LAST CHECKED NOV 2026
Stages
GrowthSeedSeries ASeries B
Sectors
biopharmaceuticalsspecialty pharmaceuticalsmedical deviceshealthcarelife sciences
FIGURES ARE AS PUBLISHED IN THE CATALOG RECORD 1 · PER-FIGURE AS-OF DATES ARE NOT YET IN THE CATALOG
Track record
Hits
Track record
Misses
Track record
Partners 9
- Gaurav Aggarwal
Managing Partner
Board seats
1 current
- Shan Fu
Managing Partner
Board seats
3 current
- Michael Chang
Managing Partner
Board seats
No public record - Kevin Dai
Partner
Board seats
No public record - Frank Kung
Managing Partner (Co-Founder)
Board seats
No public record - Albert Cha
Managing Partner
Board seats
3 current
- Mahendra Shah
Managing Director
Board seats
3 on record
- Edgar G. Engleman
Managing Partner, Chief Scientific Advisor (Co-Founder)
Board seats
1 current
- Neetesh Kumar
Managing Partner
Board seats
No public record
Reputation 2
No reputation score — basis not established for this firm.
- Vivo Capital investor profile - Fundraising Fox
fundraisingfox.com
- Vivo Capital - Wikipedia
en.wikipedia.org
Contact
Published sources only
Published contact
- Website
- www.vivocapital.com
Published sources only
GlassVC lists only contact information the firm or its sources have published. We do not list personal emails, direct lines, or private addresses.
SOURCE: FIRM WEBSITE, AS PUBLISHED 2
What founders say
Founder-submitted · Verified identity and relationship
No founder reviews yet
Be the first founder to share your experience with Vivo Capital. Reviews come from founders whose identity and relationship have been verified.
Write the first reviewMethodology
Tier basis — AUM band prong: Wikipedia reports AUM of US$5.3B as of March 2025, inside the $2B-$10B T2 band; other profiles claim about $5.8B, a variance noted here rather than averaged. Tier reflects published scale and track-record signals. It is not a rating of the firm as a partner.
Figures are shown as published; conflicting figures are never averaged. Review dimension scores appear only once three founders have reviewed this firm; profiles below that threshold do not appear in rated lists.
The catalog does not yet carry per-figure citations or as-of dates: every figure on this page traces to the catalog record listed below, and that limit is stated rather than papered over. Corrections with a source: Suggest a correction.
Source record 2
- [1]
DATABASE · GlassVC catalog — Catalog record for Vivo Capital — provenance: GlassVC catalog census, November 2026
↩ cites: AUM · Check size · Founded · HQ · Stages · Sectors · Funds · Reputation
- [2]
FIRM SITE · Vivo Capital — Firm website, as published by the firm
PROFILE BUILT FROM PUBLIC SOURCES · 2 CATALOG SOURCES · LAST CHECKED NOV 2026
